Tissue & gastrointestinal research
BPC-157 5 mg
A synthetic pentadecapeptide sequence derived from a gastric protein. Researchers are studying its effects on soft-tissue and gastrointestinal repair processes in laboratory and animal models.
What it is
BPC-157 is a synthetic 15-amino-acid sequence based on a fragment of a protein found in human gastric juice. It is used as a laboratory research chemical and is not a registered medicine in South Africa or in major international jurisdictions.
Mechanism being studied
Preclinical work has explored possible influences on angiogenesis-related signalling, nitric-oxide pathways and growth-factor receptor expression in injured tissue. These mechanisms are described in animal and cell models and have not been confirmed as clinically meaningful in people.
Human evidence
Published controlled human trials are very limited. Most available literature is animal or in-vitro work. Claims about tendon, ligament or gut healing in people are not supported by adequate human evidence at this time.
Safety considerations
Safety information for this compound is incomplete outside of controlled settings. Reported considerations in the literature include injection-site reactions, unknown long-term effects, product-quality and sterility risks with unregistered preparations, and unpredictable interactions with existing medicines or conditions. Any consideration of use belongs with a registered healthcare professional who can assess the individual clinical picture.
Regulatory status
Not approved for human therapeutic use. Regulators including SAHPRA have warned about unregistered peptide products marketed to the public. Availability is subject to applicable law and licensed channels.
Certificate of analysis
Third-party analytical documentation for this compound is published for transparency and professional review. It confirms identity and purity of tested material only, and is not a marketing authorisation, a registration, or a recommendation for use.
View certificate (PDF)Key references
- SAHPRA — Public communications on unregistered peptide and injectable products.
- Peer-reviewed preclinical literature indexed in PubMed under 'BPC 157'.
- World Anti-Doping Agency Prohibited List — non-approved substances (S0).
References are provided as reading directions for professionals. They do not constitute endorsement of any use.
Information only — availability subject to applicable law, prescription/authorisation, and licensed healthcare/pharmacy channels. Nothing on this page is an offer to sell, and no dosing or self-administration guidance is provided.
South Africa — compliance notice
SAHPRA has publicly warned about unregistered peptide products being marketed to the South African public. In general, products intended to diagnose, treat, or otherwise alter bodily functions require registration or authorisation before they may lawfully be sold. ELLIVON BIOSCIENCES publishes reference information only and directs all clinical questions to registered healthcare professionals and licensed pharmacy channels.